Cyclacel Pharmaceuticals Stock Forecast

A very red day for Cyclacel Pharmaceuticals stock price after a -5.61% fall in the Thursday trading session
(Updated on Apr 18, 2024)

CYCC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cyclacel Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.23. On a fall, the stock will find some support from the short-term average at $1.83. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen -5.61%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cyclacel Pharmaceuticals stock

Cyclacel Pharmaceuticals finds support from accumulated volume at $1.76 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.140 between high and low, or 7.69%. For the last week the stock has had daily average volatility of 14.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CYCC) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Cyclacel Pharmaceuticals to open at $1.88, and during the day (based on 14 day Average True Range), to move between $1.66 and $2.04, which gives a possible trading interval of +/-$0.193 (+/-10.41%) up or down from last closing price. If Cyclacel Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 20.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.76 (4.86%) than the resistance at $1.96 (5.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cyclacel Pharmaceuticals stock A Buy?

Cyclacel Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.049 Strong Sell Candidate Downgraded

Predicted Opening Price for Cyclacel Pharmaceuticals of Friday, April 19, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.